A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

The International Society for the Biological Therapy of Cancer (iSBTc) has initiated in collaboration with the United States Food and Drug Administration (FDA) a programmatic look at innovative avenues for the identification of relevant parameters to assist clinical and basic scientists who study th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Butterfield, Lisa H, Disis, Mary L, Fox, Bernard A, Lee, Peter P, Khleif, Samir N, Thurin, Magdalena, Trinchieri, Giorgio, Wang, Ena, Wigginton, Jon, Chaussabel, Damien, Coukos, George, Dhodapkar, Madhav, Håkansson, Leif, Janetzki, Sylvia, Kleen, Thomas O, Kirkwood, John M, Maccalli, Cristina, Maecker, Holden, Maio, Michele, Malyguine, Anatoli, Masucci, Giuseppe, Palucka, A Karolina, Potter, Douglas M, Ribas, Antoni, Rivoltini, Licia, Schendel, Dolores, Seliger, Barbara, Selvan, Senthamil, Slingluff, Craig L, Stroncek, David F, Streicher, Howard, Wu, Xifeng, Zeskind, Benjamin, Zhao, Yingdong, Zocca, Mai-Britt, Zwierzina, Heinz, Marincola, Francesco M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Commentary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630944/
https://ncbi.nlm.nih.gov/pubmed/19105846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-81
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados